| scholarly article | Q13442814 |
| P50 | author | Andrea O Rossetti | Q38799099 |
| P2860 | cites work | Pathophysiology of status epilepticus. | Q30464084 |
| Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience | Q33961525 | ||
| No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease"). | Q34147041 | ||
| The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome | Q34220515 | ||
| Sodium valproate vs phenytoin in status epilepticus: a pilot study | Q79975956 | ||
| Randomized study of intravenous valproate and phenytoin in status epilepticus | Q80579530 | ||
| [Interest of the ketogenic diet in a refractory status epilepticus in adults] | Q80932302 | ||
| Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting | Q83978234 | ||
| Propofol treatment of refractory status epilepticus: a study of 31 episodes | Q34330637 | ||
| Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. | Q34434411 | ||
| Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review | Q34570571 | ||
| Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus | Q34674978 | ||
| A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group | Q34752382 | ||
| The use of topiramate in refractory status epilepticus | Q35054480 | ||
| Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures | Q35129615 | ||
| Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane | Q35864521 | ||
| Status epilepticus: pathophysiology and management in adults | Q36400934 | ||
| Literature review, case report, and expert discussion of prolonged refractory status epilepticus | Q36404830 | ||
| The anaesthetic and intensive care of status epilepticus | Q36757314 | ||
| The surgical treatment of status epilepticus | Q37106012 | ||
| The pharmacokinetics of agents used to treat status epilepticus | Q37919931 | ||
| Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus | Q40170165 | ||
| Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers | Q42595309 | ||
| Phenytoin penetration into brain after administration of phenytoin or fosphenytoin | Q43516403 | ||
| A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus | Q43731006 | ||
| Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus | Q43747004 | ||
| Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia | Q46112055 | ||
| Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy | Q46171083 | ||
| Bowel ischemia: a rare complication of thiopental treatment for status epilepticus | Q46227874 | ||
| In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. | Q46252806 | ||
| Ketamine successfully terminates malignant status epilepticus | Q46356877 | ||
| Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin | Q46362016 | ||
| Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy | Q46390833 | ||
| Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus | Q46536834 | ||
| Hypothermia for refractory status epilepticus. | Q46642470 | ||
| It's time to revise the definition of status epilepticus | Q46722956 | ||
| Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. | Q46740274 | ||
| Refractory status epilepticus: effect of treatment aggressiveness on prognosis | Q46802749 | ||
| Determinants of success in the use of oral levetiracetam in status epilepticus | Q46958134 | ||
| Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours | Q47336100 | ||
| N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. | Q48211788 | ||
| Vagus nerve stimulation for refractory status epilepticus | Q48487077 | ||
| Prolonged coma from refractory status epilepticus | Q48575285 | ||
| Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus | Q48612069 | ||
| A "malignant" variant of status epilepticus | Q48786227 | ||
| Prolongation of midazolam half-life after sustained infusion for status epilepticus. | Q51408618 | ||
| Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade. | Q51635829 | ||
| Double-blind Study of Lorazepam and Diazepam in Status Epilepticus | Q51854987 | ||
| Pharmacokinetics of high-dose pentobarbital in severe head trauma. | Q54792322 | ||
| Status Epilepticus | Q59664579 | ||
| Intravenous valproic acid for myoclonic status epilepticus | Q73556165 | ||
| Intravenous valproate is well tolerated in unstable patients with status epilepticus | Q74298443 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | status epilepticus | Q980709 |
| P304 | page(s) | 100-112 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Current treatment options in neurology | Q26842298 |
| P1476 | title | Treatment options in the management of status epilepticus | |
| Treatment Options in the Management of Status Epilepticus | |||
| P478 | volume | 12 |
Search more.